Skip to main content

JHU Spinoff Thrive Earlier Detection Corp. Raises $257M in Funding

Thrive Earlier Detection Corp., a JHU cancer diagnostic spinoff, has raised $257 million in new funding to advance development of CancerSEEK, a liquid biopsy test designed to detect multiple types of cancer at early stages - “...we welcome the opportunity, with these investments, to remain focused on our mission to make the earlier detection of cancer a routine part of medical care," said CEO Dave Daly. According to the Baltimore Business Journal, Thrive has grown to have over 100 employees, including 42 people based in a research and development space in Baltimore. The company recently expanded its Baltimore lab space to about 20,000 sq.ft.

Read More

Michele Whelley - President & CEO

"We want you to be informed about Greater Baltimore. Don't be shy; please ask."

Michele Whelley
President & CEO

We are here to help you!

If you've landed on this site, then you have questions about us, and we want to help. We know that your time is crucial, and getting access to us should not be a complicated thing. Drop us a note via one of the options below and we will get back to you within 24 hours.

(410) 864-9927